Current Report Filing (8-k)
August 12 2022 - 4:03PM
Edgar (US Regulatory)
0001788028
false
0001788028
2022-08-12
2022-08-12
0001788028
JSPR:VotingCommonStockParValue0.0001PerShareMember
2022-08-12
2022-08-12
0001788028
JSPR:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfVotingCommonStockAtExercisePriceOf11.50Member
2022-08-12
2022-08-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported): August 12, 2022
JASPER
THERAPEUTICS, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-39138 |
|
84-2984849 |
(State or other jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
of incorporation) |
|
|
|
Identification No.) |
2200
Bridge Pkwy Suite #102 |
|
|
Redwood
City, CA |
|
94065 |
(Address of principal
executive offices) |
|
(Zip Code) |
(650)
549-1400
Registrant’s
telephone number, including area code
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which
registered |
Voting Common Stock,
par value $0.0001 per share |
|
JSPR |
|
The
Nasdaq Stock Market LLC |
Redeemable Warrants,
each whole warrant exercisable for one share of Voting Common Stock at an exercise price of $11.50 |
|
JSPRW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934.
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02.
Results of Operations and Financial Condition.
On
August 12, 2022, Jasper Therapeutics, Inc. issued a press release reporting its financial results for the quarter ended June 30, 2022
and providing a corporate update. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In
accordance with General Instructions B.2 of Form 8-K, the information in this Item 2.02, including the press release attached hereto
as Exhibit 99.1, is being furnished under Item 2.02 and Item 9.01 of Current Report on Form 8-K and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
JASPER THERAPEUTICS, INC. |
|
|
|
Date: August
12, 2022 |
By: |
/s/ Jeet Mahal |
|
|
Name: Jeet Mahal |
|
|
Title: Chief Operating Officer
and
Chief Financial Officer |
2
Amplitude Healthcare Acq... (NASDAQ:AMHCU)
Historical Stock Chart
From Sep 2024 to Oct 2024
Amplitude Healthcare Acq... (NASDAQ:AMHCU)
Historical Stock Chart
From Oct 2023 to Oct 2024